Breakpoints

113 Folgen

1. #73 – You’re a Breakpoint, Harry: Magical Insights from CLSI and USCAST

   Vom: 24.3.2023
2. #72 – This Isn't Just a Phage: A Discussion on Bacteriophage Therapy

   Vom: 17.3.2023
3. #71 – This is a Potential Breakup Song: Controversies in the Management of Infective Endocarditis

   Vom: 17.2.2023
4. #70 – Stewardship Struggles

   Vom: 20.1.2023
5. #69 – IDWeek 2022 Recap: Practice Changing Publications – Midnights Edition

   Vom: 30.12.2022
6. #68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials

   Vom: 23.12.2022
7. #67 – Nixing the Nidus: Managing Retained Sources in Prosthetic Joint Infections

   Vom: 25.11.2022
8. #66 – The Swinging PEN-dulum: Evolving Approaches to Cephalosporin Use in Penicillin Allergic Patients

   Vom: 18.11.2022
9. #65 – Into the Unknown: Exploring Fever of Unknown Origin with Febrile Podcast

   Vom: 14.10.2022
10. #64 – Putting the Fun in Fungi: A Fun-guide to New Antifungals

    Vom: 23.9.2022
11. #63 – I Never Metapneumovirus that Required Antibiotics: Prevention & Treatment of Common Respiratory Viruses in Adults

    Vom: 16.9.2022
12. #62 – Novel TheraPOOtics: The Microbiome, C. difficile, and LBPs

    Vom: 26.8.2022
13. #61 – Dosing Consult: Linezolid Therapeutic Drug Monitoring

    Vom: 19.8.2022
14. #60 – Going MAD for Non-COVID ID Literature: A Year in Review LIVE from MAD-ID

    Vom: 22.7.2022
15. #59 – Resistance in Pseudomonas aeruginosa: Pearls and Perils

    Vom: 15.7.2022
16. #58 – We're Gonorrhea-valuate: Updates and Implementation of STI Treatment Guidelines

    Vom: 24.6.2022
17. #57 – Dosing Consult: Ceftriaxone

    Vom: 27.5.2022
18. #56 – Empiric Escalation: Gazing into the Crystal Ball for Multidrug-Resistant Gram-Negatives

    Vom: 15.4.2022
19. #55 – One World: Global Perspectives in Antimicrobial Stewardship

    Vom: 25.3.2022
20. #54 – Connecting with our Colleagues: COVID-19 Treatments in Community Pharmacies

    Vom: 18.3.2022